Abstract
Abstract
Background
There are conflicting reports on the factors that increase the likelihood of patients dying from follicular thyroid carcinoma (FTC). Therefore, it is critical to identify risk factors of patients with FTC. This study aimed to identify the factors that increase the risk of death of patients with FTC and help clinicians make better treatment and follow-up decisions.
Methods
A systematic literature review was conducted in PubMed and Web of Science databases for relevant studies published before January 31, 2023. Their reference lists were also analyzed. Two reviewers extracted data and evaluated the quality of eligible studies independently. Studies on patients who had open thyroidectomy procedures with or without neck dissection were included in this review. The RevMan 5.3 software was used to analyze the data.
Results
This meta-analysis included thirteen studies with a total of 2075 patients. The following variables were associated with an increased risk of death in FTC patients: age > 45 years, male, tumor diameter > 4 cm, multifocality, extrathyroidal extension (ETE), widely invasive (WI), cervical lymph node metastasis (CLNM), distant metastases (DM) and non-radical resection tumor. Lobectomy and no radioactive iodine (RAI) treatment was not associated with the death of FTC patients.
Conclusion
Clinicians should pay closer attention to the following significant risk factors associated with the death of FTC patients: age (> 45), male, multifocality, tumor diameter > 4 cm, ETE, WI, non-radical resection tumor, CLNM, and DM. Individualized initial treatment and close follow-up are needed FTC patients who have these risk factors.
Funder
the Scientific Research Foundation of The Education Department of Liaoning Province
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference58 articles.
1. G. Huang, H. Lu, M. Li, Q. Lv, Q. Chen, Association of total cholesterol and atherosclerotic cardiovascular disease in patients with follicular thyroid cancer: A real-world study from Chinese populations. Medicine (Baltimore) 100, e27310 (2021)
2. Z.W. Baloch, S.L. Asa, J.A. Barletta, R.A. Ghossein, C.C. Juhlin, C.K. Jung, V.A. LiVolsi, M.G. Papotti, M. Sobrinho-Simões, G. Tallini, O. Mete, Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33, 27–63 (2022)
3. A. D’Avanzo, P. Treseler, P.H. Ituarte, M. Wong, L. Streja, F.S. Greenspan, A.E. Siperstein, Q.Y. Duh, O.H. Clark, Follicular thyroid carcinoma: histology and prognosis. Cancer 100, 1123–1129 (2004)
4. M.P. Gronlund, J.S. Jensen, C.H. Hahn, C.H. Gronhoj, C. Gronhoj, C.V. Buchwald, Risk Factors for Recurrence of Follicular Thyroid Cancer: A Systematic Review. Thyroid 31, 1523–1530 (2021)
5. Z. Wang, C. Mo, L. Chen, L. Kong, K. Wu, Y. Zhu, X. Chen, Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma. Updates Surg 74, 735–746 (2022)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献